Nearly 100 percent of women reject tamoxifen drug despite claims that it prevents breast cancer
(NaturalNews) A study published in the journal Breast Cancer Research and Treatment has found that women overwhelmingly reject the breast cancer prevention drug tamoxifen even when given a thorough, personalized analysis of its risks and benefits. University of Michigan researchers administered the information about the drug to 632 women and found that only one percent of participants actually ended up taking it.Originally formulated to prevent recurrences in women who have already had breast cancer, tamoxifen is now being touted as a breast cancer prevention drug.The women who participated in the study were given detailed information about how the drug would work for them based on a number of personalized factors. These included medical and family history, age, and race. After completion,…
http://www.medworm.com/index.php?rid=3110925&cid=s_36976_91_f&fid=36976&url=http%3A%2F%2Fwww.NaturalNews.com%2F027788_Tamoxifen_brst_cancer.html
